Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients
- PMID: 32436355
- PMCID: PMC7280645
- DOI: 10.1111/andr.12821
Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients
Abstract
Background: The pandemic of new severe acute respiratory syndrome (SARS) due to coronavirus (CoV) 2 (SARS-CoV-2) has stressed the importance of effective diagnostic and prognostic biomarkers of clinical worsening and mortality. Epidemiological data showing a differential impact of SARS-CoV-2 infection on women and men have suggested a potential role for testosterone (T) in determining gender disparity in the SARS-CoV-2 clinical outcomes.
Objectives: To estimate the association between T level and SARS-CoV-2 clinical outcomes (defined as conditions requiring transfer to higher or lower intensity of care or death) in a cohort of patients admitted in the respiratory intensive care unit (RICU).
Materials and methods: A consecutive series of 31 male patients affected by SARS-CoV-2 pneumonia and recovered in the respiratory intensive care unit (RICU) of the "Carlo Poma" Hospital in Mantua were analyzed. Several biochemical risk factors (ie, blood count and leukocyte formula, C-reactive protein (CRP), procalcitonin (PCT), lactate dehydrogenase (LDH), ferritin, D-dimer, fibrinogen, interleukin 6 (IL-6)) as well as total testosterone (TT), calculated free T (cFT), sex hormone-binding globulin (SHBG), and luteinizing hormone (LH) were determined.
Results: Lower TT and cFT were found in the transferred to ICU/deceased in RICU group vs groups of patients transferred to IM or maintained in the RICU in stable condition. Both TT and cFT showed a negative significant correlation with biochemical risk factors (ie, the neutrophil count, LDH, and PCT) but a positive association with the lymphocyte count. Likewise, TT was also negatively associated with CRP and ferritin levels. A steep increase in both ICU transfer and mortality risk was observed in men with TT < 5 nmol/L or cFT < 100 pmol/L.
Discussion and conclusion: Our study demonstrates for the first time that lower baseline levels of TT and cFT levels predict poor prognosis and mortality in SARS-CoV-2-infected men admitted to RICU.
Keywords: COVID-19; inflammatory markers; mortality; prognosis; sex hormones.
© 2020 American Society of Andrology and European Academy of Andrology.
Conflict of interest statement
The authors declare that there are no conflicts of interest in connection with this article.
Figures
Comment in
-
Testosterone levels in COVID-19: More data, but how do we proceed?Andrologia. 2021 Aug;53(7):e14088. doi: 10.1111/and.14088. Epub 2021 Apr 27. Andrologia. 2021. PMID: 33908078 No abstract available.
References
-
- Porcheddu R, Serra C, Kelvin D, et al. Similarity in case fatality rates (CFR) of COVID‐19/SARS‐COV‐2 in Italy and China. J Infect Dev Ctries. 2020;14:125‐128. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
